Coronado Explorations Ltd. Appoints Senior V.P. Health Products and Nutraceuticals.Business Editors and Health Writers LONDON--(BUSINESS WIRE)--Feb. 7, 2002 Coronado Explorations Ltd. (The Company)(OTCBB OTCBB See OTC Bulletin Board (OTCBB). :COOX) announced today that its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. Naturol Inc., (www.naturol.net), has appointed Curt Hendrix M.Sc. as Senior Vice President, Health Products and Nutraceuticals. On January 23rd 2002 The Company announced that it had completed a merger with Naturol Inc., a Nevada Corporation which holds the exclusive North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. license to proprietary, leading edge, cost effective technology for extraction of bioactive compounds from plants. Curt Hendrix has over forty years experience in the natural health sciences and dietary supplement industry and is recognized by the medical profession as a foremost authority in this area. Over the years Curt Hendrix has researched and created one of the most substantial databases of medical knowledge on the treatment of illness using natural health products. His monographs and research publications are approved by physicians and taught to physicians, pharmacists and other health care providers in the U.S. Curt Hendrix has researched and published scientific monographs on the treatment, through natural medicines, of Depression, Cognitive Decline, Alzheimer's, Hypercholesterolemia Hypercholesterolemia Definition Hypercholesterolemia refers to levels of cholesterol in the blood that are higher than normal. Description Cholesterol circulates in the blood stream. It is an essential molecule for the human body. , Benign Prostatic Hyperplasia benign prostatic hyperplasia n. Abbr. BPH A nonmalignant enlargement of the prostate gland commonly occurring in men after the age of 50, and sometimes leading to compression of the urethra and obstruction of the flow of urine. and Prostate Cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. , Migraine, Osteoarthritis osteoarthritis or osteoarthrosis or degenerative joint disease Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first. , Irritable Bowel Syndrome irritable bowel syndrome (IBS), condition characterized by frequently alternating constipation and diarrhea in the absence of any disease process. It is usually accompanied by abdominal pain, especially in the lower left quadrant, bloating, and flatulence. and Congestive Heart Failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. . Curt Hendrix was recently awarded a patent on a natural medication formulation for the treatment of Migraine which is currently undergoing clinical trials by Kaiser Permanente and is also published in the book "What your doctor may not tell you about Migraines," written by Dr.'s Alexander and Mauskop. Curt Hendrix has also conducted pioneering work in providing health alternatives in the area of obesity and weight loss. Naturol Inc. is dedicated to becoming a global leader in the commercialization of technology for the production of low cost, high quality extracts from natural materials. Naturol's proprietary technologies offer a benign and cost effective alternative to current extraction technologies and will produce high quality extracts to be used in the $2.8 billion U.S. market for pharmaceutical, nutraceuticals, flavors and fragrances. Forward Looking Statements. The statements in this press release regarding the merger, future opportunities and any other effect, result or aspect of the transaction and any other statements, which are not historical fact, are forward looking statements. Such statements involve risks and uncertainties, including, but not limited to, costs and difficulties related to the integration of acquired businesses, costs, delays, and any other difficulties related to the merger, risks and effects of legal and administrative proceedings and governmental regulation, future financial and operational results, competition, general economic conditions and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereto or to reflect the occurrence of unanticipated events. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion